Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP566403.RAPaSJxThMBUjUchvYqErVyOQdFuNUWZFSfO-L2SP7xHY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP566403.RAPaSJxThMBUjUchvYqErVyOQdFuNUWZFSfO-L2SP7xHY130_assertion type Assertion NP566403.RAPaSJxThMBUjUchvYqErVyOQdFuNUWZFSfO-L2SP7xHY130_head.
- NP566403.RAPaSJxThMBUjUchvYqErVyOQdFuNUWZFSfO-L2SP7xHY130_assertion wasGeneratedBy ECO_0000203 NP566403.RAPaSJxThMBUjUchvYqErVyOQdFuNUWZFSfO-L2SP7xHY130_provenance.
- NP566403.RAPaSJxThMBUjUchvYqErVyOQdFuNUWZFSfO-L2SP7xHY130_assertion wasDerivedFrom befree-2016 NP566403.RAPaSJxThMBUjUchvYqErVyOQdFuNUWZFSfO-L2SP7xHY130_provenance.
- NP566403.RAPaSJxThMBUjUchvYqErVyOQdFuNUWZFSfO-L2SP7xHY130_assertion SIO_000772 16938365 NP566403.RAPaSJxThMBUjUchvYqErVyOQdFuNUWZFSfO-L2SP7xHY130_provenance.
- NP566403.RAPaSJxThMBUjUchvYqErVyOQdFuNUWZFSfO-L2SP7xHY130_assertion evidence source_evidence_literature NP566403.RAPaSJxThMBUjUchvYqErVyOQdFuNUWZFSfO-L2SP7xHY130_provenance.
- NP566403.RAPaSJxThMBUjUchvYqErVyOQdFuNUWZFSfO-L2SP7xHY130_assertion description "[Since small cell lung cancers (SCLC) have one of the highest reported frequencies of functional abnormalities in the pRB protein (90%) of any human cancer, we wish to assess to what extent E2F3 would be overexpressed in this and other classes of human lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP566403.RAPaSJxThMBUjUchvYqErVyOQdFuNUWZFSfO-L2SP7xHY130_provenance.